Jan Lessem

Jan Lessem discloses dealings in EPIRUS Biopharmaceuticals, Inc. to SEC (Form 4). Between 26 January 2006 and 15 September 2006, the trades on record add up to 17 filings.

Sales make up the whole of the open-market record (15 sales, €56k). Outside the open market, there are 1 share grant and 1 option exercise.

The latest filing, published on 18 September 2006, reports an open-market sale of €2,760 in EPIRUS Biopharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.